Return to homepagePandemic Pact

GBi2S: Rapid development of pathogen-neutralizing human monoclonal antibodies (MEMUMAB).

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:0 publications

Grant number: 03LW0049

Grant search

Key facts

  • Disease

    Severe Acute Respiratory Syndrome (SARS)

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $68,086.1

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Twincore, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A